July 2022

A listing of the individual articles included in the Jurisdiction E Medicare A News bulletin dated July 2022 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
ACT Questions and Answers - March 23, 2022 Revised
Additional Documentation Request (ADR) Responses On-Demand Tutorials Available
Advance Beneficiary Notice of Noncoverage On-Demand Tutorials Available
April 2022 I/OCE Specifications Version 23.1 CR12648
BDX-XL2 (L37054) - R3 - Effective April 28, 2022
Billing and Coding MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) Final Billing and Coding Article - Effective August 08, 2022
Billing and Coding MolDX: Melanoma Risk Stratification Molecular Testing (A57268) Final Billing and Coding Article - Effective August 08, 2022
Billing and Coding Outpatient Cardiac Rehabilitation - R9 - Effective January 1, 2022
Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices - R10 - Effective April 1, 2022
Billing and Coding: BDX-XL2 (A57356) - R2 - Effective April 28, 2022
Billing and Coding: Complex Drug Administration Coding (A58532) R8 - Effective June 11, 2022
Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) (A56706) Retirement - Effective June 1, 2022
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) R8 - Effective April 1, 2022
Billing and Coding: MolDX: APC and MUTYH Gene Testing (A57352) Retirement - Effective August 08, 2022
Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing (A57354) Retirement - Effective August 08, 2022
Billing and Coding: MolDX: ConfirmMDx Epigenetic Molecular Assay (A57605) Retirement - Effective August 08, 2022
Billing and Coding: MolDX: Cystatin C Measurement (A57643) - R3 - Effective June 09, 2022
Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma) (A57621) R3 - Effective June 30, 2022
Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome (A54995) Retirement - Effective August 08, 2022
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) Final Billing and Coding Article - Effective August 08, 2022
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R6 - Effective April 17, 2022
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R3 - Effective June 02, 2022
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58168) - R2 - Effective March 24, 2022
Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (A57338) Retirement - Effective June 1, 2022
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R3 - Effective February 24, 2022
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R4 - Effective April 28, 2022
Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (A58183) - R2 - Effective June 02, 2022
Billing and Coding: MolDX: Progensa® PCA3 Assay (A54489) Retirement - Effective August 08, 2022
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R3 - Effective May 12, 2022
Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test for Non-Small Cell Lung Cancer (A55881) - R3 - Effective May 12, 2022
Billing and Coding: Positron Emission Tomography Scans Coverage - R33 - Article effective February 18, 2022
Billing and Coding: Positron Emission Tomography Scans Coverage - R34 - Article effective February 18, 2022
Billing and Coding: Pulmonary Rehabilitation Services - R4 - Effective May 19, 2022
Billing and Coding: Pulmonary Thromboembolectomy (A59048) - Effective July 9, 2022
Billing and Coding: Routine Foot Care (A57954) R10 - Effective June 19, 2022
Billing and Coding: Routine Foot Care (A57954) R9 - Effective June 19, 2022
Billing and Coding: Short Tandem Repeat (STR) Markers and Chimerism (CPT codes 81265-81268) (A57842) - R1 - Effective March 17, 2022
Biosimilars: Safe, Effective, and May Reduce Patient Costs
Botulinum Toxin Types A and B Policy (L35170) - R14 - Effective October 01, 2019, and associated Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R2 - Effective October 01, 2020
Calendar Year 2023 Modifications/Improvements to VBID Model – Implementation CR12688
Changes to Beneficiary Coinsurance for Additional Procedures Furnished During the Same Clinical Encounter as Certain Colorectal Cancer Screening Tests CR12656
Changes to the Laboratory NCD Edit Software for October 2022 CR12803
Chronic Care Management Services - Revised
Claim Status Category and Claim Status Codes Update CR12505
Claims Processing Instructions for the New Hepatitis B Vaccine Code 90759 CR12686
Claims Processing Instructions for the New Pneumococcal 15-valent Conjugate Vaccine Code 90671 and Pneumococcal 20-valent Conjugate Vaccine Code 90677 - Revised CR12439
CMS MLN Outpatient Rehabilitation Therapy Fact Sheet
Collaborative Patient Care is a Provider Partnership
Cost Report Education On-Demand Tutorials Available
COVID-19: New Administration Code 0074A for Pfizer Pediatric Vaccine Booster Dose
— 50 Items per Page
Showing 1 - 50 of 132 results.